Drug Approval Package

Evista (Raloxifene Hydrochloride) Tablets
Company:  Eli Lilly & Co.
Application No.:  020815/S003
Approval Date: 9/30/1999

• Approval Letter(s) (PDF) (591 KB)

• Final Printed Labeling
  Part 1 (PDF) (2.1 MB)
  Part 2 (PDF) (2.2 MB)

• Medical Review(s)
  Part 1 (PDF) (2.8 MB)
  Part 2 (PDF) (2.7 MB)
  Part 3 (PDF) (2.9 MB)
  Part 4 (PDF) (2.7 MB)
  Part 5 (PDF) (2.7 MB)
  Part 6 (PDF) (2.4 MB)

• Statistical Review(s) (PDF) (1.5 MB)

• Clinical Pharmacology Biopharmaceutics Review(s)
  Part 1 (PDF) (2.9 MB)
  Part 2 (PDF) (3 MB)
  Part 3 (PDF) (3 MB)
  Part 4 (PDF) (2.8 MB)

• Administrative Document(s)/Correspondence
  Part 1 (PDF) (2.6 MB)
  Part 2 (PDF) (2.6 MB)
  Part 3 (PDF) (2.4 MB)
  Part 4 (PDF) (2.7 MB)

Date created: June 20, 2001

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.